Plasma CRP levels rise within 48 h following myocardial infarction and inversely correlate with prognosis in acute coronary syndromes (ACS), suggesting that therapeutic CRP reduction may improve outcomes [227,228]. This evidence concerns the gene CRP and acute coronary syndrome.